In this study, the qRT-PCR, western blot assays, bioinformatics analyses, and the dual-luciferase reporter assay showed that circASH2L competes with VEGFA for binding to miR-665, thereby playing an oncogenic role in ovarian cancer. Here, VEGFA is linked to ovarian carcinoma.